← All companies
Mirum Pharmaceuticals, Inc.
MIRM - Company ID 0001759425
Market cap$7.79 B
Rank#1100
Filings600
The table below shows Mirum Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $296.68M | $222.50M | $286.33M | $28.00M | $31.34M | $142.09M |
| Short-term investments | $86.64M | $57.81M | $0.00 | $123.72M | $125.20M | $89.73M |
| Receivables | $123.33M | $78.29M | $67.97M | $23.99M | $3.27M | - |
| Inventory | $24.89M | $22.40M | $22.31M | $5.57M | $1.51M | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.